Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.55 USD | +0.57% | -6.08% | +561.08% |
May. 31 | Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target | MT |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+561.08% | 194M | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+2.07% | 22.39B | |
-10.79% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Wedbush Lifts Elevation Oncology's Price Target to $6 From $4 on 'Impressive' Data, Keeps Outperform Rating